IV: intravenous; EEG: electroencephalography; PLP: pyridoxal 5'-phosphate; PNPO: pyridoxamine 5'-phosphate oxidase.
* Risk of apnea, particularly when pyridoxine is given IV.
¶ Repeated every 5 to 15 minutes up to a maximum of 500 mg with continuous EEG monitoring.
Δ Obtain genetics consultation if genetic analysis is nondiagnostic.
◊ Obtain genetics consultation if genetic analysis is nondiagnostic. If molecular genetic analysis unavailable, can confirm by significantly reduced sulfite oxidase enzyme activity in cultured fibroblasts.Do you want to add Medilib to your home screen?